5,071
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Hepatocyte Differentiation from iPSCs or MSCs in Decellularized Liver Scaffold: Cell–ECM Adhesion, Spatial Distribution, and Hepatocyte Maturation Profile

ORCID Icon, , , &
Article: 2061263 | Received 03 Jul 2021, Accepted 05 Oct 2021, Published online: 17 Apr 2022

References

  • Kwong A, Kim W, Lake J, Smith J, Schladt D, Skeans M, Noreen SM, Foutz J, Booker SE, Cafarella M, et al. OPTN/SRTR 2019 annual data report: liver. Am J Transplant. 2021;21(S2):208–15. doi:10.1111/ajt.16494.
  • Iansante V, Mitry R, Filippi C, Fitzpatrick E, Dhawan A. Human hepatocyte transplantation for liver disease: current status and future perspectives. Pediatr Res. 2017;83(1–2):232–40. doi:10.1038/pr.2017.284.
  • Alizadeh E, Eslaminejad MB, Akbarzadeh A, Sadeghi Z, Abasi M, Herizchi R, Zarghami N. Upregulation of MiR-122 via trichostatin a treatments in hepatocyte-like cells derived from mesenchymal stem cells. Chem Biol Drug Des. 2016;87(2):296–305. doi:10.1111/cbdd.12664.
  • Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, Kato T, Okochi H, Ochiya T. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J Gastroenterol Hepatol. 2009;24(1):70–77. doi:10.1111/j.1440-1746.2008.05496.x.
  • Li J, Xing F, Chen F, He L, So K, Liu Y. Functional 3D human liver bud assembled from MSC-derived multiple liver cell lineages. Cell Transplant. 2018;27(1):1–12. doi:10.1177/0963689717745332.
  • Ma X, Duan Y, Tschudy-Seney B, Roll G, Behbahan IS, Ahuja TP, Tolstikov V, Wang C, McGee J, Khoobyari S, et al. Highly efficient differentiation of functional hepatocytes from human induced pluripotent stem cells. Stem Cells Transl Med. 2013;2(6):409–19. doi:10.5966/sctm.2012-0160.
  • Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Quinn G, Okochi H, Ochiya T. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology. 2007;46(1):219–28. doi:10.1002/hep.21704.
  • Szkolnicka D, Zhou W, Lucendo-Villarin B, Hay DC. Pluripotent stem cell– derived hepatocytes: potential and challenges in pharmacology. Annu Rev Pharmacol Toxicol. 2013;53(1):147–59. doi:10.1146/annurev-pharmtox-011112-140306.
  • Ang L, Tan A, Autio M, Goh S, Choo S, Lee K, Tan J, Pan B, Lee JJH, Lum JJ. A roadmap for human liver differentiation from pluripotent stem cells. Cell Rep. 2018;22(8):2190–205. doi:10.1016/j.celrep.2018.01.087.
  • Nakai S, Shibata I, Shitamichi T, Yamaguchi H, Takagi N, Inoue T, Nakagawa T, Kiyokawa J, Wakabayashi S, Miyoshi T, Higashi E, Ishida S, Shiraki N, Kume S, et al. Collagen vitrigel promotes hepatocytic differentiation of induced pluripotent stem cells into functional hepatocyte- like cells. Biol Open. 2019;8(7):1. doi:10.1242/bio.042192.
  • Blackford SJI, Ng SS, Segal JM, King AJF, Austin AL, Kent D, Moore J, Sheldon M, Ilic D, Dhawan A, Mitry RR, Rashid ST, et al. Validation of current good manufacturing practice compliant human pluripotent stem cell-derived hepatocytes for cell-based therapy. Stem Cells Transl Med. 2018;1. doi:10.1002/sctm.18-0084.
  • Si-Tayeb K, Lemaigre FP, Duncan SA. Organogenesis and development of the liver. Dev Cell. 2010;18(2):175–89. doi:10.1016/j.devcel.2010.01.011.
  • Ober E, Lemaigre F. Development of the liver: insights into organ and tissue morphogenesis. J Hepatol. 2018;68(5):1049–62. doi:10.1016/j.jhep.2018.01.005.
  • Antarianto RD, Dewi AA, Pragiwaksana A, Pawitan JA. Decellularization of liver cubes using multiple site syringe injection for generating native liver scaffold: preliminary report. AIP Conf Proc. 2019;2193:040005.
  • Dewi AAAAP, Antarianto RD, Pawitan JA. Characterization of Indonesia decellularized liver cubes scaffold using scanning electron microscopy. JBBBE. 2021;52:38–46. 10.4028/www.scientific.net/JBBBE.52.38.
  • Chen KG, Mallon BS, McKay RD, Robey PG. Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics. Cell Stem Cell. 2014;14(1):13–26. doi:10.1016/j.stem.2013.12.005.
  • Induced Pluripotent Stem Cell Culture Protocols [Internet]. Sigmaaldrich.com. 2021 [cited 20 June 2021]. Available from: https://www.sigmaaldrich.com/ID/en/technical-documents/protocol/cell-culture-and-cell-culture-analysis/stem-cell-culture/human-ipsc-culture-protocols.
  • Mirdamadi E, Kalhori D, Zakeri N, Azarpira N, Solati-Hashjin M. Liver tissue engineering as an emerging alternative for liver disease treatment. Tissue Eng Part B Rev. 2020;26(2):145–63. doi:10.1089/ten.teb.2019.0233.
  • Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C, North PE, Dalton S, Duncan SA. Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells. Hepatology. 2010;51(1):297–305. doi:10.1002/hep.23354.
  • Minami T, Ishii T, Yasuchika K, Fukumitsu K, Ogiso S, Miyauchi Y, Kojima H, Kawai T, Yamaoka R, Oshima Y. Novel hybrid three-dimensional artificial liver using human induced pluripotent stem cells and a rat decellularized liver scaffold. Regen Ther. 2019;10:127–33. doi:10.1016/j.reth.2019.03.002.
  • Takeishi K, de L’hortet AC, Wang Y, Handa K, Guzman-Lepe J, Matsubara K, Morita K, Jang S, Haep N, Florentino RM, et al. Assembly and function of a bioengineered human liver for transplantation generated solely from induced pluripotent stem cells. Cell Rep. 2020;31(9):107711. doi:10.1016/j.celrep.2020.107711.
  • Debnath T, Shekar Mallarpu C, Kiran Chelluri L. Development of bioengineered organ using biological acellular rat liver scaffold and hepatocytes. Organogenesis. 2020;16(2):61–72. doi:10.1080/15476278.2020.1742534.
  • Ogiso S, Yasuchika K, Fukumitsu K, Ishii T, Kojima H, Miyauchi Y, Yamaoka R, Komori J, Katayama H, Kawai T, et al. Efficient recellularisation of decellularised whole-liver grafts using biliary tree and foetal hepatocytes. Sci Rep. 2016 Oct 21;6(1):1–10. doi:10.1038/srep35887.
  • Hillebrandt KH, Everwien H, Haep N, Keshi E, Pratschke J, Sauer IM. Strategies based on organ decellularization and recellularization. Transpl Int. 2019 Jun;32(6):571–85. doi:10.1111/tri.13462.
  • Ong S-Y, Dai H, Leong KW. Inducing hepatic differentiation of human mesenchymal stem cells in pellet culture. Biomaterials. 2006;27(22):4087–97. doi:10.1016/j.biomaterials.2006.03.022.
  • Aleahmad F, Ebrahimi S, Salmannezhad M, Azarnia M, Jaberipour M, Hoseini M, Talaei-Khozani T. Heparin/Collagen 3D scaffold accelerates hepatocyte differentiation of Wharton’s Jelly-derived mesenchymal stem cells. Tissue Eng Regen Med. 2017;14(4):443–52. doi:10.1007/s13770-017-0048-z.
  • Khodabandeh Z, Vojdani Z, Talaei-Khozani T, Bahmanpour S. Hepatogenic differentiation capacity of human Wharton’s jelly mesenchymal stem cell in a co-culturing system with endothelial cells in matrigel/collagen scaffold in the presence of fetal liver extract. Int J Stem Cell. 2017;10(2):218. doi:10.15283/ijsc17003.
  • Graffmann N, Ncube A, Wruck W, Adjaye J. Cell fate decisions of human iPSC-derived bipotential hepatoblasts depend on cell density. PLOS ONE. 2018;13(7):e0200416. doi:10.1371/journal.pone.0200416.
  • Muncie JM, Weaver VM. The physical and biochemical properties of the extracellular matrix regulate cell fate. Curr Top Dev Biol. 2018;130:1–37.
  • Wang B, Jakus A, Baptista P, Soker S, Soto-Gutierrez A, Abecassis M, Shah RN, Wertheim JA. Functional maturation of induced pluripotent stem cell hepatocytes in extracellular matrix—A comparative analysis of bioartificial liver microenvironments. Stem Cells Transl Med. 2016;5(9):1257–67. doi:10.5966/sctm.2015-0235.
  • Jaramillo M, Yeh H, Yarmush ML, Uygun BE. Decellularized human liver extracellular matrix (hDLM)‐mediated hepatic differentiation of human induced pluripotent stem cells (hIPSCs). J Tissue Eng Regen Med. 2018;12(4):e1962–73. doi:10.1002/term.2627.
  • Luo Y, Lou C, Zhang S, Zhu Z, Xing Q, Wang P, Liu T, Liu H, Li C, Shi W, et al. Three-dimensional hydrogel culture conditions promote the differentiation of human induced pluripotent stem cells into hepatocytes. Cytotherapy. 2018 Jan 1;20(1):95–107. doi:10.1016/j.jcyt.2017.08.008.
  • Kehtari M, Beiki B, Zeynali B, Hosseini FS, Soleimanifar F, Kaabi M, Soleimani M, Enderami SE, Kabiri M, Mahboudi H. Decellularized Wharton’s jelly extracellular matrix as a promising scaffold for promoting hepatic differentiation of human induced pluripotent stem cells. J Cell Biochem. 2019;120(4):6683–97. doi:10.1002/jcb.27965.
  • Sekine K, Tsuzuki S, Yasui R, Kobayashi T, Ikeda K, Hamada Y, Kanai E, Camp JG, Treutlein B, Ueno Y, et al. Robust detection of undifferentiated iPSC among differentiated cells. Sci Rep. 2020 Jun 24;10(1):1–9. doi:10.1038/s41598-020-66845-6.
  • Schwartz RE, Fleming HE, Khetani SR, Bhatia SN. Pluripotent stem cell- derived hepatocyte-like cells. Biotechnol Adv. 2014;32(2):504–13. doi:10.1016/j.biotechadv.2014.01.003.
  • Gieseck IIIRL, Hannan NR, Bort R, Hanley NA, Drake RA, Cameron GW, Wynn TA, Vallier L. Maturation of induced pluripotent stem cell derived hepatocytes by 3D-culture. PloS one. 2014 Jan 22;9(1):e86372. doi:10.1371/journal.pone.0086372.
  • Starokozhko V, Hemmingsen M, Larsen L, Mohanty S, Merema M, Pimentel RC, Wolff A, Emnéus J, Aspegren A, Groothuis G, et al. Differentiation of human‐induced pluripotent stem cell under flow conditions to mature hepatocytes for liver tissue engineering. J Tissue Eng Regen Med. 2018 May;12(5):1273–84. doi:10.1002/term.2659.
  • Park K, Hussein K, Hong S, Ahn C, Yang S, Park S, Kweon O-K, Kim B-M, Woo H-M. Decellularized liver extracellular matrix as promising tools for transplantable bioengineered liver promotes hepatic lineage commitments of induced pluripotent stem cells. Tissue Eng Part A. 2016;22(5–6):449–60. doi:10.1089/ten.tea.2015.0313.
  • Bertucci T, Dai G. Biomaterial engineering for controlling pluripotent stem cell fate. Stem Cells Int. 2018;2018:1–12. doi:10.1155/2018/9068203.
  • Cotovio J, Fernandes T. Production of human pluripotent stem cell-derived hepatic cell lineages and liver organoids: current status and potential applications. Bioengineering. 2020;7(2):36. doi:10.3390/bioengineering7020036.
  • Abbey D, Elwyn S, Hand N, Musunuru K, Rader D. Self‐organizing human induced pluripotent stem cell hepatocyte 3D organoids inform the biology of the pleiotropic TRIB1 gene. Hepatol Commun. 2020;4(9):1316–31. doi:10.1002/hep4.1538.
  • DeLaForest A, Di Furio F, Jing R, Ludwig-Kubinski A, Twaroski K, Urick A, Pulakanti K, Rao S, Duncan SA. HNF4A regulates the formation of hepatic progenitor cells from human iPSC-derived endoderm by facilitating efficient recruitment of RNA Pol II. Genes. 2019;10(1):21. doi:10.3390/genes10010021.
  • Viiri LE, Rantapero T, Kiamehr M, Alexanova A, Oittinen M, Viiri K, Niskanen H, Nykter M, Kaikkonen MU, Aalto-Setälä K. Extensive reprogramming of the nascent transcriptome during iPSC to hepatocyte differentiation. Sci Rep. 2019;9(1):1–2. doi:10.1038/s41598-019-39215-0.
  • Tauran Y, Poulain S, Lereau-Bernier M, Danoy M, Shinohara M, Segard BD, Kato S, Kido T, Miyajima A, Sakai Y, et al. Analysis of the transcription factors and their regulatory roles during a step-by-step differentiation of induced pluripotent stem cells into hepatocyte-like cells. Molecular Omics. 2019;15(6):383–98. doi:10.1039/C9MO00122K.